Healthcare And Life Sciences Sectors Witness Rapid Growth - Pharmaceuticals & Healthcare Insight

Government's Contribution To Health Expenditure Forecast To Decline

Industry / Finland In 2008, Finnish health expenditure reached EUR14.9bn (US$21.9bn) and by 2009 it is expected to top EUR15.4bn. However, as a result of the weakening euro, health expenditure in US dollar terms will decline...

Healthcare And Life Sciences Sectors Witness Rapid Growth

Industry / Finland News: The Finnish healthcare and life sciences sectors have witnessed a very rapid growth in recent years, reports Engineering News. Basic research in enzymes and drug discovery has helped to develop highly...

Cerepro Approved On A Named Patient Basis

Industry / Finland Finland's National Agency for Medicines has approved Ark Therapeutics' Cerepro (sitimagene ceradenovec) on a named patient basis. The drug is a novel gene-based therapy, developed as an orphan drug,...

Growth In Drug Reimbursements Remain Under 5% As Budgeted

Industry / Finland In 2008, expenditure on the reimbursement of medicines in Finland increased to EUR1.24bn (US$1.68bn), equating to an 8.8% rise in value from 2007. Additionally, sales of reimbursed drugs reached EUR1.17bn...

Coping With Spiralling Drug Costs

Industry / Finland A new report from the London School of Economics assessing the pharmaceutical policies in Finland has identified a number of challenges and possible methods for overcoming rising drug expenditure in...